$ERAS
Erasca, Inc.

2022 Q1 Form 10-Q Financial Statement

#000095017022009720 Filed on May 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $7.076M $3.682M
YoY Change 92.18% 128.55%
% of Gross Profit
Research & Development $27.43M $12.25M
YoY Change 124.0% 168.88%
% of Gross Profit
Depreciation & Amortization $403.0K $149.0K
YoY Change 170.47% 23.14%
% of Gross Profit
Operating Expenses $36.51M $19.61M
YoY Change 86.18% 218.04%
Operating Profit -$36.51M -$19.61M
YoY Change 86.18%
Interest Expense $114.0K $30.00K
YoY Change 280.0% -83.78%
% of Operating Profit
Other Income/Expense, Net $47.00K $1.590M
YoY Change -97.04% -19975.0%
Pretax Income -$36.46M -$18.02M
YoY Change 102.35% -23.84%
Income Tax
% Of Pretax Income
Net Earnings -$36.46M -$18.02M
YoY Change 102.35% -23.84%
Net Earnings / Revenue
Basic Earnings Per Share -$0.31
Diluted Earnings Per Share -$305.1K -$151.5K
COMMON SHARES
Basic Shares Outstanding 121.6M
Diluted Shares Outstanding 119.5M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $392.5M $212.3M
YoY Change 84.86%
Cash & Equivalents $333.3M $170.0M
Short-Term Investments $59.19M $42.35M
Other Short-Term Assets $10.84M $2.004M
YoY Change 440.97%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $403.4M $214.3M
YoY Change 88.19%
LONG-TERM ASSETS
Property, Plant & Equipment $20.41M $3.799M
YoY Change 437.12%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $29.22M $5.000M
YoY Change 484.48%
Other Assets $5.126M $1.485M
YoY Change 245.19%
Total Long-Term Assets $72.10M $10.28M
YoY Change 601.04%
TOTAL ASSETS
Total Short-Term Assets $403.4M $214.3M
Total Long-Term Assets $72.10M $10.28M
Total Assets $475.5M $224.6M
YoY Change 111.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.712M $1.042M
YoY Change 352.21%
Accrued Expenses $14.27M $6.770M
YoY Change 110.84%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $21.39M $11.21M
YoY Change 90.75%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $29.42M $1.875M
YoY Change 1468.85%
Total Long-Term Liabilities $29.42M $1.875M
YoY Change 1468.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $21.39M $11.21M
Total Long-Term Liabilities $29.42M $1.875M
Total Liabilities $50.81M $13.09M
YoY Change 288.17%
SHAREHOLDERS EQUITY
Retained Earnings -$274.6M
YoY Change
Common Stock $700.2M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $424.7M -$129.3M
YoY Change
Total Liabilities & Shareholders Equity $475.5M $224.6M
YoY Change 111.67%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$36.46M -$18.02M
YoY Change 102.35% -23.84%
Depreciation, Depletion And Amortization $403.0K $149.0K
YoY Change 170.47% 23.14%
Cash From Operating Activities -$25.81M -$15.67M
YoY Change 64.73% 179.25%
INVESTING ACTIVITIES
Capital Expenditures $7.336M $122.0K
YoY Change 5913.11% -121.86%
Acquisitions
YoY Change
Other Investing Activities $5.542M -$40.00K
YoY Change -13955.0% -102.58%
Cash From Investing Activities -$1.794M -$162.0K
YoY Change 1007.41% -116.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 460.0K 120.5M
YoY Change -99.62% 24499.39%
NET CHANGE
Cash From Operating Activities -25.81M -15.67M
Cash From Investing Activities -1.794M -162.0K
Cash From Financing Activities 460.0K 120.5M
Net Change In Cash -27.14M 104.7M
YoY Change -125.92% -2636.56%
FREE CASH FLOW
Cash From Operating Activities -$25.81M -$15.67M
Capital Expenditures $7.336M $122.0K
Free Cash Flow -$33.14M -$15.79M
YoY Change 109.92% 212.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001761918
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-03-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-40602
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
ERASCA, INC.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-1217027
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3115 Merryfield Row
CY2022Q1 dei Trading Symbol
TradingSymbol
ERAS
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92121
CY2022Q1 dei City Area Code
CityAreaCode
858
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
465-6511
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
121857705
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
333347000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
360487000
CY2022Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
59186000
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
53988000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10841000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5542000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
403374000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
420017000
CY2022Q1 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
29224000
CY2021Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
44770000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20405000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15954000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16932000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17356000
CY2022Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
408000
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
408000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5126000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2910000
CY2022Q1 us-gaap Assets
Assets
475469000
CY2021Q4 us-gaap Assets
Assets
501415000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
4712000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4677000
CY2022Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
16665000
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
21419000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
14000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
285000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
21391000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
26381000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
29416000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
18506000
CY2022Q1 us-gaap Liabilities
Liabilities
50807000
CY2021Q4 us-gaap Liabilities
Liabilities
44887000
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
80000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
80000000
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
121732846
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
121382547
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
119875630
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
119102505
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
12000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
12000
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
700225000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
694844000
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-951000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-162000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-274624000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-238166000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
424662000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
456528000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
475469000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
501415000
CY2022Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
27429000
CY2021Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
12245000
CY2022Q1 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
2000000
CY2021Q1 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
3680000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7076000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3682000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
36505000
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
19607000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-36505000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-19607000
CY2022Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
114000
CY2021Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
30000
CY2022Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
67000
CY2021Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
55000
CY2021Q1 eras Change In Fair Value Of Preferred Stock Purchase Right Liability
ChangeInFairValueOfPreferredStockPurchaseRightLiability
1615000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
47000
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1590000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-36458000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-18017000
CY2022Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.81
CY2022Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
119491433
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22233422
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-789000
CY2021Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-1000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-37247000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18018000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
456528000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
460000
CY2022Q1 eras Stock Issued During Period Value Vesting Of Early Exercised Stock Options
StockIssuedDuringPeriodValueVestingOfEarlyExercisedStockOptions
479000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4442000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-36458000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-789000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
424662000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-113984000
CY2021Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1680000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
94000
CY2021Q1 eras Stock Issued During Period Value Vesting Of Early Exercised Stock Options
StockIssuedDuringPeriodValueVestingOfEarlyExercisedStockOptions
174000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
795000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-18017000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-129259000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-36458000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-18017000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
403000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
149000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4442000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
795000
CY2022Q1 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
2000000
CY2021Q1 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
3680000
CY2022Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-17000
CY2021Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-13000
CY2021Q1 eras Change In Fair Value Of Preferred Stock Purchase Right Liability
ChangeInFairValueOfPreferredStockPurchaseRightLiability
1615000
CY2022Q1 eras Increase Decrease In Prepaid Expenses And Other Current And Long Term Assets
IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndLongTermAssets
5515000
CY2021Q1 eras Increase Decrease In Prepaid Expenses And Other Current And Long Term Assets
IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndLongTermAssets
1158000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1898000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
175000
CY2022Q1 eras Increase Decrease In Accrued Expenses And Other Current Liabilities
IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities
-3656000
CY2021Q1 eras Increase Decrease In Accrued Expenses And Other Current Liabilities
IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities
353000
CY2022Q1 eras Increase Decrease In Operating Lease Assets And Liabilities Net
IncreaseDecreaseInOperatingLeaseAssetsAndLiabilitiesNet
-11063000
CY2021Q1 eras Increase Decrease In Operating Lease Assets And Liabilities Net
IncreaseDecreaseInOperatingLeaseAssetsAndLiabilitiesNet
41000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-25806000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15666000
CY2022Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
9758000
CY2021Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
21990000
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
19300000
CY2021Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
27950000
CY2022Q1 us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
2000000
CY2021Q1 us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
6000000
CY2022Q1 us-gaap Payments To Acquire Equity Securities Fv Ni
PaymentsToAcquireEquitySecuritiesFvNi
2000000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7336000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
122000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1794000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-162000
CY2021Q1 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
119393000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
460000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1144000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
460000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
120537000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-27140000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
104709000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
360895000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
65688000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
333755000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
170397000
CY2021Q1 eras Issuance Of Common Stock In Connection With Asset Acquisition
IssuanceOfCommonStockInConnectionWithAssetAcquisition
1680000
CY2022Q1 eras Amounts Accrued For Purchase Of Property And Equipment
AmountsAccruedForPurchaseOfPropertyAndEquipment
1324000
CY2022Q1 eras Vesting Of Early Exercised Options
VestingOfEarlyExercisedOptions
479000
CY2021Q1 eras Vesting Of Early Exercised Options
VestingOfEarlyExercisedOptions
174000
CY2021Q1 eras Amounts Accrued For Deferred Offering Costs
AmountsAccruedForDeferredOfferingCosts
183000
CY2022Q1 eras Tenant Improvement Allowance Included In Operating Lease Liabilities
TenantImprovementAllowanceIncludedInOperatingLeaseLiabilities
6483000
CY2022Q1 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
392500000
CY2022Q1 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
29200000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-274600000
CY2022Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On July 9, 2021, the Company effected a one-for-1.2 reverse stock split of its issued and outstanding shares of common stock (the Reverse Stock Split).
CY2021Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
1.2
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;min-width:fit-content;">Use of estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Arial;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;min-width:fit-content;">The preparation of the Company’s condensed consolidated financial statements in conformity with US GAAP requires the Company to make estimates and assumptions that impact the reported amounts of assets, liabilities, expenses, and the disclosure of contingent assets and liabilities in the condensed consolidated financial statements and accompanying notes. Accounting estimates and management judgments reflected in the condensed consolidated financial statements include, but are not limited to, the accrual of research and development expenses, fair value of common stock, preferred stock and freestanding instruments, stock-based compensation expense, and the incremental borrowing rate for determining the operating lease asset and liability. Management evaluates its estimates on an ongoing basis. Although estimates are based on the Company’s historical experience, knowledge of current events, and actions it may undertake in the future, actual results may ultimately materially differ from these estimates and assumptions.</span></p>
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
408000
CY2022Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
408000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
333347000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
169989000
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
408000
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
408000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
333755000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
170397000
CY2022Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2022Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
89361000
CY2022Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
952000
CY2022Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000
CY2022Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
88410000
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
98920000
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
162000
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
98758000
CY2022Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
17
CY2022Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
61200000
CY2022Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
0
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
19
CY2021Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
68000000.0
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
22535000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
17681000
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2130000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1727000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20405000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15954000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
403000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
149000
CY2022Q1 eras Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
8498000
CY2021Q4 eras Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
9122000
CY2022Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
4569000
CY2021Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
7275000
CY2022Q1 eras Unvested Early Exercised Stock Option Liability
UnvestedEarlyExercisedStockOptionLiability
2405000
CY2021Q4 eras Unvested Early Exercised Stock Option Liability
UnvestedEarlyExercisedStockOptionLiability
2884000
CY2022Q1 eras Accrued Property And Equipment Current
AccruedPropertyAndEquipmentCurrent
722000
CY2021Q4 eras Accrued Property And Equipment Current
AccruedPropertyAndEquipmentCurrent
1272000
CY2022Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
205000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
383000
CY2022Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
266000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
483000
CY2022Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
16665000
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
21419000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
121732846
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
121382547
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
119875630
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
119102505
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
The restricted stock vests 25% one year from the vesting commencement date and monthly thereafter over a three-year period and is subject to repurchase by the Company in the event of any voluntary or involuntary termination of services to the Company prior to vesting.
CY2022Q1 eras Shares Of Common Stock Subject To Repurchase
SharesOfCommonStockSubjectToRepurchase
121530
CY2021Q4 eras Shares Of Common Stock Subject To Repurchase
SharesOfCommonStockSubjectToRepurchase
212674
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
91144
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
91147
CY2022Q1 eras Share Based Compensation Arrangement By Share Based Payment Award Shares Subject To Repurchase
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToRepurchase
1615888
CY2021Q4 eras Share Based Compensation Arrangement By Share Based Payment Award Shares Subject To Repurchase
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesSubjectToRepurchase
1854427
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0146
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0174
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0059
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0101
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.8586
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.8599
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.834
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.839
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y29D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4442000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
795000
CY2022Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
35404483
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
29685655
CY2022Q1 eras Operating Leases Cancelable And Non Cancellable Expiration Dates
OperatingLeasesCancelableAndNonCancellableExpirationDates
2032
CY2022Q1 eras Operating Leases Non Cancelable Expiration Dates
OperatingLeasesNonCancelableExpirationDates
2026
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1000000.0
CY2022Q1 us-gaap Variable Lease Cost
VariableLeaseCost
117000
CY2022Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
31000
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
361000
CY2021Q1 us-gaap Variable Lease Cost
VariableLeaseCost
105000
CY2021Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
29000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
273000
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
268000
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y10M2D
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.070
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y10M9D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.069
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
14000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
5026000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5177000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
5333000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
5493000
CY2022Q1 eras Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
30568000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
51611000
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
15698000
CY2022Q1 eras Lessee Operating Lease Liability Tenant Improvement Allowance Receivable
LesseeOperatingLeaseLiabilityTenantImprovementAllowanceReceivable
6483000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
29430000
CY2022Q1 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0
CY2021Q1 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0
CY2022Q1 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
0
CY2022Q1 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
0
CY2021Q1 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
0
CY2021Q1 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
0
CY2021Q1 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2022Q1 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-36458000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-18017000
CY2022Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
119491433
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22233422
CY2022Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.81
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19541698
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
84548625

Files In Submission

Name View Source Status
0000950170-22-009720-index-headers.html Edgar Link pending
0000950170-22-009720-index.html Edgar Link pending
0000950170-22-009720.txt Edgar Link pending
0000950170-22-009720-xbrl.zip Edgar Link pending
eras-20220331.htm Edgar Link pending
eras-20220331.xsd Edgar Link pending
eras-20220331_cal.xml Edgar Link unprocessable
eras-20220331_def.xml Edgar Link unprocessable
eras-20220331_htm.xml Edgar Link completed
eras-20220331_lab.xml Edgar Link unprocessable
eras-20220331_pre.xml Edgar Link unprocessable
eras-ex10_1.htm Edgar Link pending
eras-ex10_2.htm Edgar Link pending
eras-ex31_1.htm Edgar Link pending
eras-ex31_2.htm Edgar Link pending
eras-ex32_1.htm Edgar Link pending
eras-ex32_2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
img197763597_0.jpg Edgar Link pending
img205567398_0.jpg Edgar Link pending
img205567398_1.jpg Edgar Link pending
img205567398_10.jpg Edgar Link pending
img205567398_11.jpg Edgar Link pending
img205567398_12.jpg Edgar Link pending
img205567398_13.jpg Edgar Link pending
img205567398_14.jpg Edgar Link pending
img205567398_15.jpg Edgar Link pending
img205567398_16.jpg Edgar Link pending
img205567398_17.jpg Edgar Link pending
img205567398_18.jpg Edgar Link pending
img205567398_19.jpg Edgar Link pending
img205567398_2.jpg Edgar Link pending
img205567398_20.jpg Edgar Link pending
img205567398_21.jpg Edgar Link pending
img205567398_22.jpg Edgar Link pending
img205567398_23.jpg Edgar Link pending
img205567398_24.jpg Edgar Link pending
img205567398_25.jpg Edgar Link pending
img205567398_26.jpg Edgar Link pending
img205567398_27.jpg Edgar Link pending
img205567398_28.jpg Edgar Link pending
img205567398_29.jpg Edgar Link pending
img205567398_3.jpg Edgar Link pending
img205567398_30.jpg Edgar Link pending
img205567398_31.jpg Edgar Link pending
img205567398_32.jpg Edgar Link pending
img205567398_33.jpg Edgar Link pending
img205567398_34.jpg Edgar Link pending
img205567398_35.jpg Edgar Link pending
img205567398_36.jpg Edgar Link pending
img205567398_37.jpg Edgar Link pending
img205567398_38.jpg Edgar Link pending
img205567398_39.jpg Edgar Link pending
img205567398_4.jpg Edgar Link pending
img205567398_40.jpg Edgar Link pending
img205567398_41.jpg Edgar Link pending
img205567398_42.jpg Edgar Link pending
img205567398_43.jpg Edgar Link pending
img205567398_44.jpg Edgar Link pending
img205567398_45.jpg Edgar Link pending
img205567398_46.jpg Edgar Link pending
img205567398_47.jpg Edgar Link pending
img205567398_48.jpg Edgar Link pending
img205567398_49.jpg Edgar Link pending
img205567398_5.jpg Edgar Link pending
img205567398_50.jpg Edgar Link pending
img205567398_51.jpg Edgar Link pending
img205567398_52.jpg Edgar Link pending
img205567398_53.jpg Edgar Link pending
img205567398_54.jpg Edgar Link pending
img205567398_55.jpg Edgar Link pending
img205567398_56.jpg Edgar Link pending
img205567398_57.jpg Edgar Link pending
img205567398_58.jpg Edgar Link pending
img205567398_59.jpg Edgar Link pending
img205567398_6.jpg Edgar Link pending
img205567398_60.jpg Edgar Link pending
img205567398_61.jpg Edgar Link pending
img205567398_62.jpg Edgar Link pending
img205567398_7.jpg Edgar Link pending
img205567398_8.jpg Edgar Link pending
img205567398_9.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending